| Title | Aspects of social cost concerning illicit drug use: analysis based on index numbers | |
| Authors | Marianna Diomidous1, Stelios Zimeras2 and John Mantas11. Department of Public Health, Faculty of Nursing, University of Athens, Athens, Hellas
2. Department of Statistics and Actuarial Financial Mathematics, University of the Aegean,Karlovassi, Samos, Hellas |
|
| Citation | Diomidous, M., Zimeras, S., Mantas, J.: Aspects of social cost concerning illicit drug use: analysis based on index numbers, Epitheorese Klin. Farmakol. Farmakokinet. 23(3): 107-116 (2009) | |
| Publication Date | Accepted for publication (Final Version): July 1, 2009 | |
| Full Text Language | English | |
| Order – Buy | Ηλεκτρονική Μορφή: pdf (10 €) – Digital Type: pdf (10 €)pharmakonpress[at]pharmakonpress[.]gr | |
| Keywords | Illicit drugs, estimation, social cost, index numbers. | |
| Other Terms | review article | |
| Summary | The trafficking and use of illicit drugs has a wide range of social consequences for both individuals and society. The current article focuses on relevant parameters concerning the estimation of social cost regarding illicit drugs, by reviewing recent relevant social cost studies. Parameters of drug use that should be taken into account for the estimation of the cost include various consequences to the user, family, wider community, industry and the public sector. Cost-of-illness studies recognize three categories: health cost, productivity losses and other impact on society. The potential benefits of cost estimation, gives rise to policy and investment decisions by highlighting specific problems and policies. A number of recent reports have provided estimates of the total economic and social costs of drug misuse in particular situations. Most of the studies use the human capital technique mainly due to the fact that this method is simpler in technical terms, with only a few studies using the demographic approach by estimating the intangible costs of illicit drug use. The development of improved economic cost estimates will be the means for prioritising substance abuse issues on policy agendas and provide useful information for targeting interventions. | |
| References | 1. Kopp P., Fenoglio P.: Calculating the social cost of illicit drugs. Methods and tools for estimating the social cost of the use of psychotropic substances. Council of Europe Publishing, 20022. Deardorff A.: Terms of Trade Glossary of International Economics. USA, 2006
3. MacDonald Z., Tinsley L., Collingwood J., Jamieson P., Pudney S.: Measuring the harm from illegal drugs using the Drug Harm Index. Home Office, UK, 2005 4. Single E., Collins D., Easton B., Harwood H., Lapsley H., Kopp P., Wilson E.: International Guidelines for Estimating the Costs of Substance Abuse. Canadian Center on Substance Abuse. Toronto, Canada, 2002 5. Godfrey C., Eaton G., McDougall C., Culyer A.: The Economic Social Costs of Class A Drug Use in England and Wales. London, 2000 6. Miron J.: A Critique of Estimates of the Economic Costs of Drug Abuse. Boston, August 2003, jmiron@bu.edu 7. Jackson A.: The Costs of Drug Abuse and Drug Policy. Economics Division, Library of Parliament, Canada, 2002 8. Roberts M., Bewley-Taylor D., Trace M.: Monitoring Drug Policy Outcomes: The Measurement of Drug-related Harm, Report 9. The Beckley Foundation, Drug Policy Programme, UK, 2006 9. Gossop M., Marsden J., Stewart D., Kidd T.: The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Society for the Study of Addiction to Alcohol and Other Drugs. London, UK, 2002 10. Collins D.J., Lapsley H.M.: Counting the Cost: estimates of the social costs of drug abuse in Australia, 1998 to 1999. Commonwealth Department of Health and Ageing. Canberra, 2002 11. Roberts M., Klein A., Trace M.: Towards a review of global policies on illegal drugs, Beckley Report One. London, UK, 2003 12. The Economic Costs of drug abuse in the United States 1992–2002. Office of National Drug Control Policy, USA, 2004 13. The Economic Costs of drug abuse the United States 1992–1998. Office of National Drug Control Policy, USA, 2000 14. Cave J., Godfrey C.: Economics of Addiction and Drugs. UK, 2005 15. Single E., Robson L., Xie X., Rehm J.: The Costs of Substance Abuse in Canada. Highlights of a major study of the health, social and economic costs associated with the use of alcohol, tobacco and illicit drugs. Canadian Centre on Substance Abuse. Canada, 1996 16. Cameron C., Trivedi P.: Microeconometrics: Methods and Applications. Cambridge University Press, New York, 2005 17. Allen R.G.D.: Index numbers in theory and practice. Macmillan, London, 1975 18. Wooldridge J.: Econometric Analysis of Cross Section and Panel Data. MIT Press, Cambridge, MA, 2002 19. Stefanis C.N.: 2007 NATIONAL REPORT (2006 data) TO THE EMCDDA by the Reitox National Focal Point GREECE, New Development, Trends and in-depth information on selected issues. 20. Ikle D.M.: A New Approach to the Index Number Problem. Quarterly Journal of Economics 86: 188-211 (1972) |
|
| Relative Papers |
Online ISSN 1011-6575
Άρθρα Δημοσιευμένα σε αυτό το Περιοδικό Καταχωρούνται στα:
- Chemical Abstracts
- Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in: • Chemical Abstracts • Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE SCImago Journal and Country Rank Factor
Συντακτικη Επιτροπή-Editorial Board
| ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ 2009 – ANNUAL SUBSCRIPTION 2009 | |
| Γλώσσα Πλήρους Κειμένου – Full Text Language | Αγγλικά – English |
| Παραγγελία – Αγορά – Order – Buy | Ηλεκτρονική Μορφή: pdf (70 €) – Digital Type: pdf (70 €)pharmakonpress[at]pharmakonpress[.]gr |
| Έντυπη Μορφή (70 € + έξοδα αποστολής) – Printed Type (70 € + shipping)pharmakonpress[at]pharmakonpress[.]gr | |